BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chia CS, Glehen O, Bakrin N, Decullier E, You B, Gilly FN, Passot G. Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface Malignancies. Ann Surg Oncol 2015;22 Suppl 3:S880-7. [PMID: 26040606 DOI: 10.1245/s10434-015-4644-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Fedyanin MY, Tryakin AA, Ter-ovanesov MD, Tyulyandin SA. DIAGNOSTICS, TREATMENT AND PROGNOSIS IN PATIENTS WITH COLORECTAL CANCER AND PERITONEAL CARCINOMATOSIS (review). Koloproktologiâ 2020;19:131-149. [DOI: 10.33878/2073-7556-2020-19-4-131-149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Katdare N, Bhatt A, Glehen O. Biomarkers in the Management of Peritoneal Metastases. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Koumpa FS, Xylas D, Konopka M, Galea D, Veselkov K, Antoniou A, Mehta A, Mirnezami R. Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research. Gastroenterol Res Pract. 2019;2019:5180895. [PMID: 31065262 DOI: 10.1155/2019/5180895] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
4 Lemoine L, Sugarbaker P, Van der Speeten K. Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. International Journal of Hyperthermia 2017;33:582-92. [DOI: 10.1080/02656736.2017.1291999] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
5 Rovers KP, Simkens GA, Punt CJ, van Dieren S, Tanis PJ, de Hingh IH. Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review. Crit Rev Oncol Hematol 2017;114:53-62. [PMID: 28477747 DOI: 10.1016/j.critrevonc.2017.03.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
6 Chirac P, Maillet D, Leprêtre F, Isaac S, Glehen O, Figeac M, Villeneuve L, Péron J, Gibson F, Galateau-sallé F, Gilly F, Brevet M. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array. Human Pathology 2016;55:72-82. [DOI: 10.1016/j.humpath.2016.04.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]